Skip to content
Lower risk Drug recall · FDA · Published March 22, 2021

Novo Nordisk Saxenda Sample Recall: Temperature Storage Issues

Novo Nordisk recalls Saxenda (liraglutide) samples due to improper cold storage causing potential product damage. Affected samples were stored below 32°F, risking cartridge and pen-injector damage.

🇺🇸 FDA recall #D-0618-2021DrugNovo Nordisk ›
Take action

Contact the company

Recalling firmNovo Nordisk Inc800 Scudders Mill Rd · Plainsboro, NJ 08536-1606
✎ GovInfoNow plain-language explainer

Novo Nordisk is recalling Saxenda (liraglutide) injection samples that were stored at temperatures below 32°F. This improper storage could damage the cartridge and pen-injector, making the product ineffective or unsafe to use. Read more at govinfonow.com/recall/36251-novo-nordisk-saxenda-sample-recall-temperature-storage-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/36251-novo-nordisk-saxenda-sample-recall-temperature-storage-issues · Updated October 4, 2026 · FDA enforcement record: FDA #D-0618-2021

Cite this page

“Novo Nordisk Saxenda Sample Recall: Temperature Storage Issues.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36251-novo-nordisk-saxenda-sample-recall-temperature-storage-issues. Based on FDA recall #D-0618-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0618-2021%22&limit=1).

The FDA announced on March 22, 2021, that Novo Nordisk Inc. recalled Saxenda (liraglutide) Injection samples due to temperature abuse hazards. The agency stated the products were stored below required temperatures, risking efficacy loss and device damage.

How to tell if you have it

  • Brand: Novo Nordisk
  • Product: Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only
  • NDC: 0169-2800-90 (Pen), 0169-2800-97 (Kit)
  • Lot Codes: K1620A1 (Kit); B2020A (Kit); I2320A (Kit); H1020A (Kit); J0520A(Kit) and KZFH714 (Pen)
  • Expiration Dates: 05/31/2022; 11/30/2021
  • Distribution: Nationwide in the USA

The hazard

The recall addresses temperature abuse where product samples were stored at temperatures below 32* F, violating storage requirements. This condition could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Context

GovInfoNow's records show Novo Nordisk Inc. has had four other recalls since April 27, 2016. Recent brand recalls include the December 19, 2025 Wegovy recall for hair in syringes and the July 5, 2017 Dial-A-Dose recall for cracking hazards. Other recent recalls of similar products include the June 10, 2026 McKesson Gemcitabine Injection recall for temperature storage risk and the January 16, 2026 McKesson UDENYCA Injection recall due to temperature abuse risk.

How to tell if you have this one

Check for Saxenda (liraglutide) injection samples with the following identifiers: 1 x 3 mL Prefilled Pen, Sample. Not for resale. NDC 0169-2800-90 (Pen), NDC 0169-2800-97 (Kit), or specific batch codes like K1620A1 (Kit).

  • Brand
    Novo Nordisk
  • Category
    Drug
FDA recall event · 13 products

All 13 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Status
    Terminated
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lotsClassNDC
D-0611-2021Fiasp FlexTouch (insulin aspart injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk, Inc., Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-3204-90 (Pen), NDC 0169-3204-97 (Kit); KP51207 exp 06/30/2022; KP52618 exp 10/31/2022Class I0169-3201-11, 0169-3201-90, 0169-3204-15, 0169-3204-90, 0169-3204-97, 0169-3205-11, 0169-3205-15, 0169-3205-91, 0169-3205-95, 0169-3206-11, 0169-3206-15, 0169-3206-91, 0169-3206-95
D-0612-2021Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3205-91; KS6BF84, Exp 06/30/2022Class I0169-3201-11, 0169-3201-90, 0169-3204-15, 0169-3204-90, 0169-3204-97, 0169-3205-11, 0169-3205-15, 0169-3205-91, 0169-3205-95, 0169-3206-11, 0169-3206-15, 0169-3206-91, 0169-3206-95
D-0613-2021Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3201-90; KS6BX63 exp 10/31/2022; KS6AK76 exp 05/31/2022; KS6BR92 exp 09/30/2022Class I0169-3201-11, 0169-3201-90, 0169-3204-15, 0169-3204-90, 0169-3204-97, 0169-3205-11, 0169-3205-15, 0169-3205-91, 0169-3205-95, 0169-3206-11, 0169-3206-15, 0169-3206-91, 0169-3206-95
D-0614-2021Levemir FlexTouch (insulin detemir) injection, 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6438-90 (Pen), NDC 0169-6438-98 (Kit); KP51933 exp 07/31/2022Class I0169-3687-12, 0169-3687-92, 0169-6438-10, 0169-6438-90, 0169-6438-97, 0169-6438-98, 0169-6432-55, 0169-6432-10
D-0615-2021NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit); KS6BS11, Exp 11/30/2021Class I0169-7501-11, 0169-7501-90, 0169-3303-12, 0169-3303-91, 0169-3303-90, 0169-6339-10, 0169-6339-90, 0169-6339-97, 0169-6339-98, 0169-6338-10, 0169-6338-90, 0169-6338-97, 0169-2001-90, 0169-2100-11, 0169-2101-12, 0169-2101-25
D-0616-2021NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90; JZFC826 exp 06/30/2021; KZFM305 exp 08/31/2022Class I0169-7501-11, 0169-7501-90, 0169-3303-12, 0169-3303-91, 0169-3303-90, 0169-6339-10, 0169-6339-90, 0169-6339-97, 0169-6339-98, 0169-6338-10, 0169-6338-90, 0169-6338-97, 0169-2001-90, 0169-2100-11, 0169-2101-12, 0169-2101-25
D-0617-2021OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx only, Novo Nordisk Inc, Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-4132-90 (Pen), NDC 0169-4132-97 (Kit); KP50867, exp 10/31/2022, KP53021, exp 04/30/2023, KP52338, exp 02/28/2023, JP54354, exp 08/31/2022, KP50676, exp 10/31/2022, KP51434, exp 11/30/2022, KP51491, exp 11/30/2022, KP51781, exp 01/31/2023, KP52249, exp 01/31/2023, KP52270, exp 01/31/2023, KP52722, exp 01/31/2023, KP52973, exp 01/31/2023, KP53031, exp 01/31/2023, KP53221, exp 12.04.2023, KP53369, exp 01/31/2023Class II—
D-0618-2021Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-2800-90 (Pen), NDC 0169-2800-97 (Kit); K1620A1 (Kit); KZFH714 (Pen) exp 05/31/2022; B2020A (Kit); JZFF482 (Pen) exp 11/30/2021; I2320A (Kit); KZFH714 (Pen) exp 05/31/2022; H1020A (Kit); KZFH714 (Pen) exp 05/31/2022; J0520A(Kit); KZFH714 (Pen) exp 05/31/2022Class II0169-2800-15, 0169-2800-90, 0169-2800-97
D-0619-2021TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Movo Mordisk Inc., Plainsboro, NJ 08536, NDC 0169-2660-90 (Pen), NDC 0169-2660-97 (Kit); JP52771 exp 09/30/2021; JP53136 exp 06/30/2021; KP50575 exp 01/31/2022; KP50976 exp 01/31/2022; KP51813 exp 04/30/2022; KP52035 exp 04/30/2022; KP52117 exp 04/30/2022; KP52440 exp 06/30/2022; KP52461 exp 04/30/2022; KP52616 exp 06/30/2022; JP52361 exp 08/01/2021Class I0169-2660-15, 0169-2660-90, 0169-2660-97, 0169-2550-13, 0169-2550-90, 0169-2550-97, 0169-2662-11, 0169-2662-90
D-0620-2021TRESIBA (insulin degludec injection) 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-2662-90; JZFE233 exp 11/30/2021Class I0169-2660-15, 0169-2660-90, 0169-2660-97, 0169-2550-13, 0169-2550-90, 0169-2550-97, 0169-2662-11, 0169-2662-90
D-0621-2021TRESIBA FlexTouch (insulin degludec injection) 200 units/mL (U-200), 3 mL Prefilled Pen, Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2550-90 (Pen), 0169-2550-97 (Kit); KP52829 exp 07/31/2022; JP54181 exp 09/30/2021; KP51059 exp 11/30/2021; KP51865 exp 11/30/2021; KP54179 exp 11/30/2022; JP52179 exp 08/16/2021Class I0169-2660-15, 0169-2660-90, 0169-2660-97, 0169-2550-13, 0169-2550-90, 0169-2550-97, 0169-2662-11, 0169-2662-90
D-0622-2021ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagesvaerd, Denmark NDC 0169-4060-90 (Pen), 0169-4060-99 (Kit); I2419A (Kit); JS68K86 (Pen) exp 05/31/2021Class II0169-4060-13, 0169-4060-12, 0169-4060-90, 0169-4060-97, 0169-4060-98, 0169-4060-99
D-0623-2021Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2911-90 (Pen) NDC 0169-2911-97 (Kit); JP54291, exp 06/20/2021Class I0169-2911-15, 0169-2911-90, 0169-2911-97
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify if your Saxenda sample has the NDC codes 0169-2800-90 (Pen) or 0169-2800-97 (Kit), or batch codes like K1620A1 (Kit).

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Mar 22, 202112. Published in FDA’s Enforcement Report: Apr 21, 202123. FDA classified it Class II: Jun 10, 202134. FDA terminated the recall: Dec 9, 2022420212022
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Novo Nordisk recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0618-2021 (March 22, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0618-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA